Stemline Therapeutics to Present at the 2014 Wells Fargo

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Stemline Therapeutics to Present at the 2014 Wells Fargo Securities Healthcare Conference

NEW YORK, June 10, 2014 (GLOBE NEWSWIRE) -- Stemline Therapeutics, Inc. (Nasdaq: STML ) announced today that Ivan Bergstein, M.D., Stemline's CEO, will present at the 2014 Wells Fargo Securities Healthcare Conference on Tuesday, June 17, 2014 at 4:05PM ET. The conference will be held at the InterContinental Hotel in Boston, MA. A live webcast of the presentation can be viewed on the Company's website at www.stemline.com .

About Stemline Therapeutics

Stemline Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel oncology therapeutics that target both cancer stem cells (CSCs) and tumor bulk in a variety of cancer types. Stemline is currently developing two clinical-stage product candidates, SL-401 and SL-701. SL-401 is a targeted therapy directed to the interleukin-3 receptor (IL-3R). SL-401 has demonstrated single-agent activity, including durable complete responses (CRs), in a Phase 1/2 trial in several indications including blastic plasmacytoid dendritic cell neoplasm (BPDCN) and relapsed or refractory acute myeloid leukemia (AML). SL-401 is being advanced into programs in BPDCN and other rare IL-3R+ malignancies, as well as additional hematologic cancers including AML and myeloma. SL-701 is an enhanced immunotherapy that activates the immune system to attack tumors. An earlier version of this therapy demonstrated clinical activity, including durable CRs and partial responses (PRs), in Phase 1/2 trials in advanced adult and pediatric brain cancers. SL-701 is being advanced into trials of adults with glioblastoma multiforme (GBM) at first recurrence, and children with non-brainstem and brainstem glioma. For more information about Stemline Therapeutics, visit www.stemline.com .

Forward-Looking Statements

Some of the statements included in this press release may be forward-looking statements that involve a number of risks and uncertainties. For those statements, we claim the protection of the safe harbor for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995. The factors that could cause our actual results to differ materially are identified from time to time in our reports filed with the Securities and Exchange Commission. Any forward-looking statements set forth in this press release speak only as of the date of this press release. We do not intend to update any of these forward-looking statements to reflect events or circumstances that occur after the date hereof.

Investor Relations Stemline Therapeutics, Inc. 750 Lexington Avenue Eleventh Floor New York, NY 10022 Tel: 646-502-2307 Email:

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Finastra Recognized as 2026 Leader in Payment Platforms

Updated Category News Views 5

Finastra Steals the Spotlight in Payments Innovation When it comes to the modern world of finance, nothing screams ‘adapt or fade into oblivion’ like the payments industry. Well, here’s a reality check from QKS Group: Finastra has snatched the spotlight in their SPARK Matrix™ for 2026 as a powerhouse in integrated bank payments platforms. Clearly, this ain’t...

Continue Reading
Jacob Walthour to Be Honored for Economic Leadership

Updated Category News Views 7

The Honoring of Leadership That Goes Beyond Business In a world where financial influence often feels like it funnels into the same familiar pockets, the news of Jacob Walthour Jr.'s upcoming recognition feels like a fresh breeze of change. The Alpha Phi Alpha's Alpha Alpha Lambda Chapter is rolling out the red carpet at its Centennial Gala for Walthour, throwing him into...

Continue Reading
2026 CEE Awards Highlight Energy Innovation Leaders

Updated Category News Views 7

Showcasing Cutting-Edge Home Energy Innovations It's that time of year again when the brightest innovators in home energy solutions get a nod from the Consortium for Energy Efficiency (CEE). This year's Integrated Home Competition spotlighted five trailblazing products that promise to reshape how we think about energy efficiency, demand flexibility, and sheer user comfort...

Continue Reading
B2B Growth Hinges on Narrative Coherence, Study Shows

Updated Category News Views 6

Clear Stories, Stronger Growth If companies can't tell a clear story that their buyers understand and believe, they're destined to stagnate. That's the blunt reality kompeld is pushing with their H2 2026 Narrative Coherence Benchmark. The report scores 150 B2B tech companies on their narrative coherence, showing there's a stark correlation between storytelling and growth....

Continue Reading
Solar Fencing Revolutionizes North Texas Homes

Updated Category News Views 6

Fences Go Solar: Welcome to the Future Land of fences and sunshine, North Texas is about to see a game changer in home improvement. Southwest Fence & Deck is rolling out the red carpet as an Authorized SOL Fence Installation Partner, putting solar power right in your backyard. Yeah, there have been sparks of innovation in plenty of fields, but who expected fences to join...

Continue Reading
Propensity Rockets to No. 70 on the 2026 Inc. 5000 List

Updated Category News Views 6

Hold onto your hats, folks—Propensity just blasted its way to Number 70 on the Inc. 5000 for 2026. That's quite a leap from the 2,591 spot just last year. If you're scratching your head wondering what's behind this meteoric rise, it’s all about AI and knowing which buyer signals really matter. The AI Advantage in B2B The B2B marketing space isn't exactly the new Wild...

Continue Reading
American Savings Bank IPO Hits NYSE: $129M Raised

Updated Category News Views 13

A Big Day for American Savings Bank Buckled up yet? Because American Savings Bank has just shot onto the NYSE, raising a hefty $129 million. A solid start, I’d say, for a Honolulu-based outfit that now struts around with a valuation tipping beyond $1.03 billion. That’s what you get when you price more than eight million shares at $16 a pop. NYSE:ASBH is the new kid on...

Continue Reading
Koogler's Sale to ALL4: A Game-Changer for the Southeast

Updated Category News Views 6

A Strategic Alignment Unfolds in Environmental Engineering Ever notice how those industry shifts often sneak up on you, only to leave a mark that's hard to ignore? That's exactly what's playing out with Koogler & Associates' recent hookup with ALL4 LLC. Set aside that coffee, this one's too important to miss if you've got a stake in the environmental consulting game or...

Continue Reading
Ransoms and Mega-Losses Surge in Cyber Claims Study

Updated Category News Views 5

Cyber Costs Skyrocket in Latest Study NetDiligence’s 2026 Cyber Claims Study isn't just another report—it’s a wake-up call. The numbers paint a stark picture: cyber incidents are burning deeper holes in pockets, and no one's immune. Whether you're a scrappy SME or a lumbering corporate giant, this report puts a magnifying glass to the chilling reality of cyber...

Continue Reading
Red Banyan Earns Top Honors in Florida for 2026

Updated Category News Views 6

Red Banyan: A Powerhouse in Reputation Management Boy, have you ever watched a company rise through the ranks almost like a caffeine kick on a drowsy morning? That's Red Banyan for you. This outfit, right out of Fort Lauderdale, snagged the '2026 Best of Florida' award as the cream of the crop in the Business Consulting Firms category. It’s like taking home an Oscar in...

Continue Reading

Top 5 Most Recently Viewed Articles

Why Ethereum Faces Sell-offs: Insights for Investors

Updated Category News Views 191

Ethereum, the world's second-largest cryptocurrency, was dealing with some serious setbacks back in 2024. The asset saw a modest gain of around 6% that year but crumbled under the pressure of a nearly 25% drop over the last three months. Meanwhile, Bitcoin surged by a staggering 50%, leaving Ethereum investors scratching their heads and raising concerns about its future...

Continue Reading
Product Analytics Market Growth Driven by AI and Consumer Insights

Updated Category News Views 115

Overview of the Product Analytics Market The Product Analytics Market is witnessing remarkable growth as businesses increasingly recognize the vital role of data insights in enhancing product efficiency and customer satisfaction. With a valuation of USD 14.73 Billion in 2023, this market is anticipated to soar to USD 84.33 Billion by 2032, demonstrating a compound annual...

Continue Reading
DA Davidson Adjusts Price Target for Manhattan Associates Stock

Updated Category News Views 61

DA Davidson Raises Price Target for Manhattan Associates DA Davidson has recently adjusted its price target for Manhattan Associates, Inc. (NASDAQ: MANH) from $285.00 to $315.00 while maintaining a robust Buy rating on the stock. This shift comes on the heels of the company’s latest quarterly results, reflecting a strong demand and an impressive initial revenue...

Continue Reading
Eli Lilly’s Kisunla Treatment Gains Approval in Japan Market

Updated Category News Views 101

Eli Lilly's Kisunla Gets the Green Light for Alzheimer's Treatment Eli Lilly And Co's Kisunla, known as donanemab, has recently been approved by Japan's Ministry of Health, Labour and Welfare. This marks a key achievement for the company as it broadens the availability of a therapy aimed at adults facing early symptomatic Alzheimer's disease (AD). This includes...

Continue Reading
Ashland's Q1 Financial Results Show Challenges and Opportunities

Updated Category News Views 234

Ashland's Financial Performance Overview Ashland Inc. (NYSE: ASH) has recently reported its financial results for the first quarter of fiscal year 2025, highlighting both challenges and strategic advancements. With sales totaling $405 million, the company experienced a 14 percent decline compared to the previous year. The decrease was influenced significantly by Portfolio...

Continue Reading